SUNNYVALE, Calif., April 29, 2011 /PRNewswire/ — Pharmacyclics,
Inc. (NASDAQ:
PCYC), a clinical stage biopharmaceutical company focused on
developing and commercializing innovative small molecule drugs for
the treatment of cancer and immune mediated diseases, today
announced that senior management will host a conference call and
live audio webcast on Wednesday, May 4th, at 4:30 pm ET to discuss
the company’s third quarter fiscal 2011 financial and operational
results. Conference Call and Webcast Details:Date: Wednesday, May
4, 2011Time: 4:30 pm ETListen via Internet: http://ir.pharmacyclics.com/events.cfm
Toll-free: +1-877-407-8133International: +1-201-689-8040The webcast
replay will be available for 30 days on the Investor Relations
section of the company’s Web site at www.pharmacyclics.com.
About PharmacyclicsPharmacyclics® is a clinical-stage
biopharmaceutical company focused on developing and commercializing
innovative small-molecule drugs for the treatment of cancer and
immune mediated diseases. Our mission and goal is to build a viable
biopharmaceutical company that designs, develops and commercializes
novel therapies intended to improve quality of life, increase
duration of life and resolve serious unmet medial healthcare needs;
and to identify promising product candidates based on scientific
development expertise, develop our products in a rapid,
cost-efficient manner and pursue commercialization and/or
development partners when and where appropriate.
Presently, Pharmacyclics has four product candidates in
clinical development and several preclinical molecules in lead
optimization. We are committed to high standards of ethics,
scientific rigor, and operational efficiency as we move each of
these programs to viable commercialization.
The Company is h
‘/>”/>
SOURCE